Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT06164327 · UNKNOWN
Trial details
- NCT number
- NCT06164327
- Sponsor
- BeBetter Med Inc
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2025-10-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.